UBS Group’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-184,891
Closed -$324K 9286
2025
Q1
$324K Buy
184,891
+94,744
+105% +$166K ﹤0.01% 4973
2024
Q4
$142K Buy
90,147
+60,271
+202% +$95.2K ﹤0.01% 5457
2024
Q3
$46.9K Buy
29,876
+10,659
+55% +$16.7K ﹤0.01% 5662
2024
Q2
$34.3K Buy
19,217
+18,915
+6,263% +$33.8K ﹤0.01% 5828
2024
Q1
$870 Sell
302
-42
-12% -$121 ﹤0.01% 7154
2023
Q4
$440 Sell
344
-64
-16% -$82 ﹤0.01% 7440
2023
Q3
$558 Sell
408
-3,204
-89% -$4.38K ﹤0.01% 7258
2023
Q2
$5.31K Buy
3,612
+1,874
+108% +$2.76K ﹤0.01% 6375
2023
Q1
$1.47K Sell
1,738
-3,924
-69% -$3.33K ﹤0.01% 7628
2022
Q4
$7.76K Sell
5,662
-4,514
-44% -$6.18K ﹤0.01% 7670
2022
Q3
$17K Buy
10,176
+1,924
+23% +$3.21K ﹤0.01% 6519
2022
Q2
$17K Buy
8,252
+2,081
+34% +$4.29K ﹤0.01% 6074
2022
Q1
$18K Buy
6,171
+3,776
+158% +$11K ﹤0.01% 6538
2021
Q4
$8K Buy
2,395
+408
+21% +$1.36K ﹤0.01% 7929
2021
Q3
$14K Buy
+1,987
New +$14K ﹤0.01% 6454
2021
Q1
Sell
-280
Closed -$4K 8172
2020
Q4
$4K Buy
+280
New +$4K ﹤0.01% 6895
2020
Q3
Sell
-90
Closed -$1K 7339
2020
Q2
$1K Buy
+90
New +$1K ﹤0.01% 6933
2020
Q1
Sell
-819
Closed -$7K 7184
2019
Q4
$7K Sell
819
-859
-51% -$7.34K ﹤0.01% 6381
2019
Q3
$12K Buy
+1,678
New +$12K ﹤0.01% 6092
2019
Q2
Sell
-197
Closed -$2K 7110
2019
Q1
$2K Buy
197
+103
+110% +$1.05K ﹤0.01% 6626
2018
Q4
$1K Sell
94
-40
-30% -$426 ﹤0.01% 6980
2018
Q3
$3K Buy
134
+9
+7% +$201 ﹤0.01% 6732
2018
Q2
$10K Buy
+125
New +$10K ﹤0.01% 6219
2018
Q1
Sell
-153
Closed -$19K 7032
2017
Q4
$19K Buy
153
+150
+5,000% +$18.6K ﹤0.01% 5632
2017
Q3
$0 Sell
3
-258
-99% ﹤0.01% 6878
2017
Q2
$31K Sell
261
-49
-16% -$5.82K ﹤0.01% 5066
2017
Q1
$61K Buy
310
+20
+7% +$3.94K ﹤0.01% 4488
2016
Q4
$78K Buy
290
+72
+33% +$19.4K ﹤0.01% 4576
2016
Q3
$86K Sell
218
-51
-19% -$20.1K ﹤0.01% 4232
2016
Q2
$92K Buy
269
+11
+4% +$3.76K ﹤0.01% 4261
2016
Q1
$214K Buy
258
+136
+111% +$113K ﹤0.01% 3737
2015
Q4
$127K Buy
122
+41
+51% +$42.7K ﹤0.01% 4075
2015
Q3
$64K Buy
81
+14
+21% +$11.1K ﹤0.01% 4518
2015
Q2
$88K Buy
67
+12
+22% +$15.8K ﹤0.01% 4380
2015
Q1
$112K Buy
55
+47
+588% +$95.7K ﹤0.01% 4119
2014
Q4
$16K Buy
+8
New +$16K ﹤0.01% 5739